Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients

NCT00166296 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

133

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Hepatitis C, Chronic

Interventions

DRUG: Escitalopram
DRUG: Placebo

Sponsor

Germans Trias i Pujol Hospital

Collaborators

[object Object]
[object Object]